INTERCEPT PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2022.
  • Intercept Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.07 USD/shares, a 101% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -1.48 USD/shares, a 126% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was 6.56 USD/shares.
  • Intercept Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -2.87 USD/shares, a 65.6% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2020 was -8.34 USD/shares, a 23.4% increase from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.56 +$9.43 Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 -$3 +$5.47 +65.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$8 +$2.55 +23.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$11 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.